
1. N Engl J Med. 2016 Jun 23;374(25):2453-64. doi: 10.1056/NEJMoa1513137.

A Worldwide Map of Plasmodium falciparum K13-Propeller Polymorphisms.

Ménard D(1), Khim N(1), Beghain J(1), Adegnika AA(1), Shafiul-Alam M(1), Amodu
O(1), Rahim-Awab G(1), Barnadas C(1), Berry A(1), Boum Y(1), Bustos MD(1), Cao
J(1), Chen JH(1), Collet L(1), Cui L(1), Thakur GD(1), Dieye A(1), Djallé D(1),
Dorkenoo MA(1), Eboumbou-Moukoko CE(1), Espino FE(1), Fandeur T(1),
Ferreira-da-Cruz MF(1), Fola AA(1), Fuehrer HP(1), Hassan AM(1), Herrera S(1),
Hongvanthong B(1), Houzé S(1), Ibrahim ML(1), Jahirul-Karim M(1), Jiang L(1),
Kano S(1), Ali-Khan W(1), Khanthavong M(1), Kremsner PG(1), Lacerda M(1), Leang
R(1), Leelawong M(1), Li M(1), Lin K(1), Mazarati JB(1), Ménard S(1), Morlais
I(1), Muhindo-Mavoko H(1), Musset L(1), Na-Bangchang K(1), Nambozi M(1), Niaré
K(1), Noedl H(1), Ouédraogo JB(1), Pillai DR(1), Pradines B(1), Quang-Phuc B(1), 
Ramharter M(1), Randrianarivelojosia M(1), Sattabongkot J(1), Sheikh-Omar A(1),
Silué KD(1), Sirima SB(1), Sutherland C(1), Syafruddin D(1), Tahar R(1), Tang
LH(1), Touré OA(1), Tshibangu-wa-Tshibangu P(1), Vigan-Womas I(1), Warsame M(1), 
Wini L(1), Zakeri S(1), Kim S(1), Eam R(1), Berne L(1), Khean C(1), Chy S(1), Ken
M(1), Loch K(1), Canier L(1), Duru V(1), Legrand E(1), Barale JC(1), Stokes B(1),
Straimer J(1), Witkowski B(1), Fidock DA(1), Rogier C(1), Ringwald P(1), Ariey
F(1), Mercereau-Puijalon O(1); KARMA Consortium.

Collaborators: Aboubacar M, Acuña JH, Andrianaranjaka V, Arévalo-Herrera M,
Aristide AA, Asih PB, Bobogare A, Brey PT, Chaijaroenkul W, Chen SB, Chileshe J, 
Chobson P, Cojean S, Coulibaly B, Deloron P, Ding XC, Djadid ND, Diop G, Djimdé
A, Doumbo OK, Durand S, Fall B, Fan Y, Fortes F, Henriques G, Hetzel MW,
Honkpehedji YJ, Hubert V, Inocêncio da Luz R, Iwagami M, Javati S, Karema C,
Kuehn A, Lamine MM, Lescano AG, Lepère JF, Lötsch F, Lu F, Luchavez JS, Lutumba
P, Madamet M, Malunga P, Mara SE, Marantina SS, Mohon AN, Monteiro W, Mueller I, 
Muhamud P, Mwanga-Amumpaire J, Nguitragool W, Nolder D, Nsango S, Nyehangane D,
Olaniyan S, Ouedraogo A, Piola P, Pirahmadi S, Raeisi A, Rodrigues Gomes L, Silai
R, Some FA, Soulama I, Texier G, Thiam A, Timinao L, Umulisa N, Vallejo AF, Van
geertruyden JP, Wang Z, Zongo I.

Author information: 
(1)The authors' affiliations are listed in the Supplementary Appendix , available
at NEJM.org.

Comment in
    N Engl J Med. 2016 Jun 23;374(25):2492-3.

BACKGROUND: Recent gains in reducing the global burden of malaria are threatened 
by the emergence of Plasmodium falciparum resistance to artemisinins. The
discovery that mutations in portions of a P. falciparum gene encoding kelch
(K13)-propeller domains are the major determinant of resistance has provided
opportunities for monitoring such resistance on a global scale.
METHODS: We analyzed the K13-propeller sequence polymorphism in 14,037 samples
collected in 59 countries in which malaria is endemic. Most of the samples
(84.5%) were obtained from patients who were treated at sentinel sites used for
nationwide surveillance of antimalarial resistance. We evaluated the emergence
and dissemination of mutations by haplotyping neighboring loci.
RESULTS: We identified 108 nonsynonymous K13 mutations, which showed marked
geographic disparity in their frequency and distribution. In Asia, 36.5% of the
K13 mutations were distributed within two areas--one in Cambodia, Vietnam, and
Laos and the other in western Thailand, Myanmar, and China--with no overlap. In
Africa, we observed a broad array of rare nonsynonymous mutations that were not
associated with delayed parasite clearance. The gene-edited Dd2 transgenic line
with the A578S mutation, which expresses the most frequently observed African
allele, was found to be susceptible to artemisinin in vitro on a ring-stage
survival assay.
CONCLUSIONS: No evidence of artemisinin resistance was found outside Southeast
Asia and China, where resistance-associated K13 mutations were confined. The
common African A578S allele was not associated with clinical or in vitro
resistance to artemisinin, and many African mutations appear to be neutral.
(Funded by Institut Pasteur Paris and others.).

DOI: 10.1056/NEJMoa1513137 
PMCID: PMC4955562
PMID: 27332904  [Indexed for MEDLINE]

